October 11, 2011

Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.

October 6, 2011

A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.

September 27, 2011

Mass merchandiser Sam's Club is offering a free women's health screening in recognition of Breast Cancer Awareness Month, the chain said Tuesday.

September 26, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis in children.

August 24, 2011


Gluten-free foods and beverages aren’t just for people with celiac disease anymore.

August 2, 2011

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

August 2, 2011

The Food and Drug Administration is looking for comments from consumers, the food industry and others about proposed labeling for gluten-free foods.

July 22, 2011

A panel of experts at the Food and Drug Administration has recommended that the agency approve a drug made by Johnson & Johnson as a treatment for ulcerative colitis in children.

July 18, 2011

The National Eczema Association, a nonprofit organization devoted to improving the health and quality of life for those living with eczema, has awarded four MD Moms products with its Seal of Acceptance, which means that the products have been evaluated to determine that they do not contain ingredients or contents that are known to be unsuitable for use by those with eczema or sensitive skin conditions.

July 18, 2011

The Food and Drug Administration has approved a drug made by Shire for treating ulcerative colitis, the British drug maker said Monday.

July 11, 2011

Upsher-Smith Labs has launched a topical medication for itching and inflammation of the skin resulting from such conditions as psoriasis and atopic dermatitis, the company said Monday.

July 7, 2011

+MD Wellness showcased its line of Gel Spa Socks that help moisturize and heal conditions like eczema, psoriasis and cracked, dry skin. Selling for a suggested $13.99, the gel is a thermoplastic rubber that does not disintegrate with use like many silicone products.

June 30, 2011

Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

June 24, 2011

Patients with inflammatory conditions may have lower rates of diabetes if they take drugs commonly used to treat arthritis, according to a new study published in the Journal of the American Medical Association.

June 13, 2011

More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

June 10, 2011

The Juvenile Diabetes Research Foundation and Selecta Biosciences have established a research collaboration to develop vaccines for Type 1 diabetes, also known as juvenile diabetes.

May 26, 2011

A milk formula for babies made by Gerber Products can reduce the risk of atopic dermatitis, and Gerber has the Food and Drug Administration’s permission to say so.

May 25, 2011

Introducing a gluten-free diet to an infant may not reduce its risk of developing Type 1 diabetes, according to a new study published in Diabetes Care.

May 18, 2011

Regional supermarket chain Fresh & Easy said that it is augmenting its gluten-free products range and will highlight the new offerings in stores through additional displays.

May 13, 2011

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

May 11, 2011

Consumers with celiac disease and gluten sensitivity now can add a popular cereal brand to their diet.

April 22, 2011

Many children with Type 1 diabetes have other autoimmune disorders as well, according to published reports.

April 12, 2011

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

March 3, 2011

The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.